IOBT Q1 2024 Earnings — IO Biotech, Inc. Revenue & Financial Results | Market Cap Arena

IOBTIO Biotech, Inc.

$21M

Q1 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$211,000

Operating Income

-$20M

Net Income

-$19M

EPS (Diluted)

$-0.30

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$25M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$128M

Total Liabilities

$13M

Stockholders' Equity

$115M

Cash & Equivalents

$118M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$211,000	-$174,000	-21.3%
Operating Income	-$20M	-$18M	-12.7%
Net Income	-$19M	-$17M	-14.2%